Fatal fetal outcome with the combined use of valsartan and atenolol

Annals of Pharmacotherapy

Volumn 35, Issue 7-8, 2001, Pages 859-861

  Briggs, G G ^a   Nageotte, M P ^a  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Atenolol; Diabetes mellitus; Fetal death; Valsartan

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; VALSARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; DIABETES MELLITUS; FEMALE; FETOTOXICITY; FETUS DEATH; FETUS ECHOGRAPHY; HUMAN; HYDRAMNIOS; LABOR INDUCTION; LUNG HYPOPLASIA; MATERNAL HYPERTENSION; NEWBORN; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; STILLBIRTH;

EID: 0034911548     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A013     Document Type: Article

References (15)

1. Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists
2. Neonatal anuria with maternal angiotensin-converting enzyme inhibition
3. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy
4. ACE inhibitor fetopathy and hypocalvaria: The kidney-skull connection
5. Effect of ACE inhibition on the fetal kidney: Decreased renal blood flow
6. Effect of atenolol on birth weight
7. Randomised controlled trial of atenolol and pindolol in human pregnancy: Effects on fetal haemodynamics
8. Congenital renal dysgenesis possibly due to captopril
9. ACE inhibitors in pregnancy
10. Are ACE inhibitors safe in pregnancy?
11. Losartan and fetal toxic effects
12. A method for estimating the probability of adverse drug reactions
13. Report of the national high blood pressure education program working group on high blood pressure in pregnancy
14. Guidelines for the management of insulin-dependent diabetes mellitus in pregnancy
15. Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy